Department of Pharmacy Practice and Translational Research, 15507University of Houston College of Pharmacy, Houston, TX, USA.
Division of Pharmacy, 4002The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Pharm Pract. 2021 Oct;34(5):800-813. doi: 10.1177/0897190020951348. Epub 2020 Sep 16.
To provide a summary of the most prominent peer-reviewed infectious diseases (ID) pharmacotherapy and Human Immunodeficiency Virus (HIV)-related articles published in 2019.
Houston Infectious Diseases Network (HIDN) members were asked to nominate articles that they believed were most influential within the ID and HIV pharmacotherapy science communities. A total of 48 general ID and 6 HIV-related articles were nominated. Following nominations, an online survey was distributed via e-mail to Society of Infectious Diseases Pharmacists (SIDP) members, with a total of 156 and 54 members voting for general ID and HIV-related articles, respectively. The results of this survey were ranked to determine the top 10 general ID and top HIV articles. The top articles were then summarized by HIDN members, including residents, fellows, and clinical pharmacists.
This review covers many of the most influential ID articles published in 2019, including 3 practice guideline updates. Due to the high rate of ID literature published each year, this review continues to help summarize these articles for the ID community, allowing clinicians to remain up-to-date on practice-changing publications in ID and HIV pharmacotherapy.
总结 2019 年发表的最具影响力的同行评议传染病(ID)药物治疗学和与人类免疫缺陷病毒(HIV)相关的文章。
休斯顿传染病网络(HIDN)成员被要求提名他们认为在 ID 和 HIV 药物治疗学科学界最有影响力的文章。共提名了 48 篇一般 ID 和 6 篇 HIV 相关文章。提名后,通过电子邮件向感染病药学协会(SIDP)成员分发了在线调查,分别有 156 名和 54 名成员投票给一般 ID 和 HIV 相关文章。根据投票结果对这些调查进行排名,以确定前 10 名一般 ID 和前 10 名 HIV 文章。然后由 HIDN 成员(包括住院医师、研究员和临床药师)对这些顶级文章进行总结。
这篇综述涵盖了 2019 年发表的许多最有影响力的 ID 文章,包括 3 项实践指南更新。由于每年发表的 ID 文献数量众多,因此本综述继续帮助 ID 社区总结这些文章,使临床医生能够及时了解 ID 和 HIV 药物治疗学领域的具有改变实践意义的出版物。